FolioLanternBeta
TEVATeva Pharmaceutical Industries Ltd

Tal Zaks

Director at Teva Pharmaceutical Industries Ltd, as of Aug 10, 2026Sold $593 of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
0.0%
share of stake sold at Teva Pharmaceutical Industries Ltd
73K
shares held after the latest filing, Teva Pharmaceutical Industries Ltd
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
2
companies filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJunJulAug 2026: $593 no plan disclosed$593AugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Teva Pharmaceutical Industries Ltd (TEVA)DirectorNov 8, 2021Aug 10, 2026
Moderna (MRNA)Former Chief Medical OfficerDec 7, 2018Jul 2, 2021

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.